Research Funding Opportunities

Latest Funding Opportunities from the UVA School of Medicine Office for Research

Menu
Featured

SAMHSA – Mental and Substance Use Disorder Practitioner Data

Purpose: The purpose of this program is to provide comprehensive data and analysis on individuals who comprise the prevention and treatment fields to address mental and substance use disorders. The…
Learn More

NIH – Diversity Program Consortium Dissemination and Translation Awards (U01-Clinical Trial Not Allowed)

Purpose: This Funding Opportunity Announcement (FOA) solicits applications from sites not currently part of the Common Fund¬†Enhancing Diversity in the Biomedical Research Workforce initiative, also known as the Diversity Program…
Learn More

NIH – Exploratory Alzheimer’s Disease Research Centers (P20 Clinical Trial Not Allowed)

Purpose: This Funding Opportunity Announcement (FOA) invites applications to establish NIA Exploratory Alzheimer's Disease Centers. NIA's primary goal in offering this P20 funding opportunity is to incentivize innovative ideas and…
Learn More

NIH – Brain Initiative: Research to Develop and Validate Advanced Human Cell-Based Assays To Model Brain Structure and Function (R01 Clinical Trial Not Allowed)

Purpose: This Funding Opportunity Announcement (FOA) encourages research grant applications directed toward developing next-generation human cell-derived assays that replicate complex nervous system architectures and physiology with improved fidelity over current…
Learn More

All Stories

NIH – Registry of Medical Cannabis Use and Health Outcomes (UM1 – Clinical Trial Optional)

Purpose: The National Institute on Drug Abuse (NIDA) seeks applications to develop and maintain a medicinal cannabis use registry to assess the medical conditions reported as reasons for using medicinal…

NIH – Pragmatic Clinical Trials in Community Settings to Decrease or Prevent VCID Outcomes, Including in Populations that Experience Health Disparities (U01 Clinical Trial Required)

Purpose: The purpose of this funding opportunity announcement (FOA) is to solicit applications for pragmatic clinical trials to decrease or prevent negative clinical outcomes due to vascular contributions to cognitive…

NIH – Data Management Coordinating Center for Diagnostic Centers of Excellence (U2C Clinical Trial Not Allowed)

Purpose: This Funding Opportunity Announcement (FOA) solicits applications for a Data Management and Coordinating Center (DMCC) to provide infrastructure, data management, and clinical research support for a new network of…

Paul G. Allen Frontiers Group

Purpose: The Paul G. Allen Frontiers Group is soliciting applications for the 2023 Allen Discovery Center (ADC) initiative to support research that will answer large, paradigm-shifting, and fundamental biological questions…

FDA – Cooperative Agreement to Support an Evidence-Based Clinical Practice Guideline for the Management of Postoperative Pain After Surgeries in Obstetric Patients (U01) Clinical Trials Not Allowed

Purpose: The U.S. Food and Drug Administration (FDA) seeks applications to develop, disseminate, implement, and evaluate an evidence-based Clinical Practice Guideline (CPG) for the management of postoperative pain in obstetric…

FDA – Cooperative Agreement to Support an Evidence-Based Clinical Practice Guideline for the Safe Tapering of Benzodiazepines (U01) Clinical Trials Not Allowed

Purpose: The U.S. Food and Drug Administration (FDA) seeks applications to develop, disseminate, implement, and evaluate an evidence-based Clinical Practice Guideline (CPG) for the safe tapering of benzodiazepines. Applicants must…